Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
QuintilesIMS
Queensland Health
Teva
Citi
Harvard Business School
Chinese Patent Office
Julphar

Generated: July 21, 2018

DrugPatentWatch Database Preview

ISOETHARINE HYDROCHLORIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Isoetharine Hydrochloride patents expire, and when can generic versions of Isoetharine Hydrochloride launch?

Isoetharine Hydrochloride is a drug marketed by Alpharma Us Pharms, Astrazeneca, Baxter Hlthcare, DEY, Intl Medication, Parke Davis, and Roxane. and is included in thirty-three NDAs.

The generic ingredient in ISOETHARINE HYDROCHLORIDE is isoetharine hydrochloride. There are four drug master file entries for this compound. Additional details are available on the isoetharine hydrochloride profile page.
Summary for ISOETHARINE HYDROCHLORIDE
Drug patent expirations by year for ISOETHARINE HYDROCHLORIDE
Synonyms for ISOETHARINE HYDROCHLORIDE
(R,*)-()-4-[1-hydroxy-2-[(1-methylethyl)amino]butyl]pyrocatechol hydrochloride
1-(3,4-Dihydroxyphenyl)-2-isopropylamino-1-butanol hydrochloride
1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)butyl)-, hydrochloride
2576-92-3
4-[1-hydroxy-2-(propan-2-ylamino)butyl]benzene-1,2-diol hydrochloride
50-96-4
79458-79-0
AC1L1L5B
AC1Q3F79
ACM2576923
BENZYL ALCOHOL, 3,4-DIHYDROXY-alpha-(1-(ISOPROPYLAMINO)PROPYL)-, HYDROCHLORIDE
BETA-2 (TN)
Bronkometer hydrochloride
CHEMBL1200920
CTK8I9431
D02093
Dilabron hydrochloride
Etyprenaline hydrochloride
Isoctarine hydrochloride
Isoetarin hydrochloride
Isoetarine hydrochloride
Isoetharine Hcl
Isoetharine hydrochloride (USP)
Isoetharine hydrochloride [USP]
Isoethraine HCl
Isoethraine hydrochloride
Isothurin hydrochloride
LS-42878
Neoisuprel hydrochloride
Neosuprel hydrochloride
Numotac hydrochloride
OR155338
SCHEMBL211343
WIN 3046

US Patents and Regulatory Information for ISOETHARINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane ISOETHARINE HYDROCHLORIDE isoetharine hydrochloride SOLUTION;INHALATION 088226-001 Sep 16, 1983 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis ISOETHARINE HYDROCHLORIDE isoetharine hydrochloride SOLUTION;INHALATION 085997-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roxane ISOETHARINE HYDROCHLORIDE isoetharine hydrochloride SOLUTION;INHALATION 087324-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Parke Davis ISOETHARINE HYDROCHLORIDE isoetharine hydrochloride SOLUTION;INHALATION 085889-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
US Army
AstraZeneca
US Department of Justice
Johnson and Johnson
Chubb
Accenture
Julphar
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.